Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimal Operative Strategies in Repair of Giant Coronary Artery Aneurysms: Case Presentation.

Surgical case reports·2026
Same author

Survival following sublobar resection after neoadjuvant therapy for T1N1-2M0 lung cancer.

PloS one·2026
Same author

Successful thoracic endovascular aortic repair for complicated Stanford type B acute aortic dissection with acute renal failure and vascular remodelling after intervention: case report and 5-year follow-up.

European heart journal. Case reports·2026
Same author

The Modified Frailty Index and Its Association With Esophagectomy Outcomes.

The Journal of surgical research·2026
Same author

[Non-anastomotic Pseudoaneurysm due to Sternal Wire Removal After Ascending Aorta Grafting:Report of a Case].

Kyobu geka. The Japanese journal of thoracic surgery·2026
Same author

Clinical outcomes of a novel sternal closure technique using tension-fixed titanium cables and a biodegradable poly-lactic acid mesh plate.

Journal of cardiothoracic surgery·2026

Related Experiment Video

Updated: May 5, 2026

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
13:04

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model

Published on: March 18, 2015

11.7K

Tissue engineering in the vasculature.

Yuji Naito1, Kevin Rocco, Hirotsugu Kurobe

  • 1Interdepartmental Program in Vascular Biology and Therapeutics, Yale University School of Medicine, New Haven, Connecticut.

Anatomical Record (Hoboken, N.J. : 2007)
|December 3, 2013
PubMed
Summary
This summary is machine-generated.

Tissue engineering offers solutions for prosthetic limitations. Tissue engineered vascular grafts (TEVGs) are advancing clinical practice, with successful pediatric implants for congenital heart disease.

Keywords:
stem celltissue engineeringvasculature

More Related Videos

Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber
09:55

Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber

Published on: May 30, 2016

8.2K
Stepwise Cell Seeding on Tessellated Scaffolds to Study Sprouting Blood Vessels
07:49

Stepwise Cell Seeding on Tessellated Scaffolds to Study Sprouting Blood Vessels

Published on: January 14, 2021

3.0K

Related Experiment Videos

Last Updated: May 5, 2026

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
13:04

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model

Published on: March 18, 2015

11.7K
Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber
09:55

Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber

Published on: May 30, 2016

8.2K
Stepwise Cell Seeding on Tessellated Scaffolds to Study Sprouting Blood Vessels
07:49

Stepwise Cell Seeding on Tessellated Scaffolds to Study Sprouting Blood Vessels

Published on: January 14, 2021

3.0K

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Materials Science

Background:

  • Traditional prosthetic materials face limitations like thrombogenicity and infection, leading to significant post-surgery morbidity and mortality.
  • Tissue engineering aims to overcome these issues by creating functional neotissue using scaffolds, cells, and signaling processes.
  • Vascular tissue engineering is a key area, with tissue engineered vascular grafts (TEVGs) showing clinical translation.

Purpose of the Study:

  • To review the historical development of tissue engineered vascular grafts (TEVGs).
  • To highlight recent advances and the current state-of-the-art in TEVG technology.
  • To discuss the potential of TEVGs in addressing limitations of traditional vascular prosthetics.

Main Methods:

  • Review of historical data and scientific literature on TEVGs.
  • Analysis of key components: scaffold materials, cell seeding, and remodeling processes.
  • Examination of clinical translation and implantation of TEVGs.

Main Results:

  • TEVGs have successfully overcome limitations of traditional materials, including thrombogenicity and infection.
  • The neotissue formation process involves seeded and host inflammatory cells guiding scaffold remodeling.
  • Successful clinical implantation of TEVGs in pediatric patients with congenital heart disease has been achieved.

Conclusions:

  • Tissue engineering provides a promising alternative to traditional vascular prosthetics.
  • TEVGs represent a significant advancement with demonstrated clinical success in pediatric applications.
  • Continued research and development in TEVGs are crucial for broader clinical adoption.